Cancer Testis Antigens and Immunotherapy: A new Dawn
Immunotherapy for cancer has been recognized as the fourth therapeutic method after surgery, radiotherapy and chemotherapy, which can prevent postoperative metastasis and recurrence and reduce or even eliminate the toxic and side effects of chemoradiotherapy. The development of successful immunother...
Main Author: | Zhang Bingcan |
---|---|
Format: | Article |
Language: | English |
Published: |
EDP Sciences
2021-01-01
|
Series: | E3S Web of Conferences |
Online Access: | https://www.e3s-conferences.org/articles/e3sconf/pdf/2021/27/e3sconf_ictees2021_02033.pdf |
Similar Items
-
Cancer testis antigen and immunotherapy
by: Krishnadas DK, et al.
Published: (2013-04-01) -
CANCER TESTIS ANTIGENS IN CANCER IMMUNOTHERAPY
by: D. I. Vodolazhsky, et al.
Published: (2017-06-01) -
Cancer-Testis Antigen Peptide Vaccine for Cancer Immunotherapy: Progress and Prospects
by: Xiao Wei, et al.
Published: (2019-05-01) -
Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?
by: Thomas C. Wirth, et al.
Published: (2017-12-01) -
Characterization of cancer/testis antigen MAGE-A11 for immunotherapy of prostate cancer
by: Dadvar, Ehsan
Published: (2014)